Aclara partners with Ipsos on Cannabis, CBD and Wellness
THE EVOLVING ROLE OF CANNABIS AND CBD IN THE LIVES OF AMERICANS
In 2021, Aclara and Ipsos partnered to deliver a syndicated research study on the role of cannabis and CBD across health and wellness. Going beyond quantitative and tracking data, this syndicated research study provides a holistic view of the traditional CPG consumer that uses cannabis.
Why this study now?
A Disruptive Product
With rapid legalization and normalization of cannabis in the US, it is positioned to become a household health and wellness product disrupting many categories
A Plant Based Stress Management Solution
Over 1 in 2 Americans are feeling more stress, anxiety, and depression, and are seeking out solutions to boost wellness
A New Retail Channel with $25 Billion Revenue
Cannabis is still federally illegal, but is sold in over 7400 retail stores and delivery services generating $25 Billion in revenue (2021)
Key Business Questions:
Demand Spaces: Why are people using cannabis in their daily lives?
Consumer Behavior Shifts: How are people shifting their health and wellness routines?
Triggers to Category Adoption: How did they first consider trying cannabis or CBD products?
The Usage Occasion: How are people using these products?
Study Components:
We put the consumer at the heart of our understanding first within our online community, then rounded out the learning with a large scale quantitative study of 1000 cannabis and CBD consumers.
Who should buy this study?
Retailers who understand the impact of channel shift
CPG Manufacturers across alcohol, wellness, Rx and OTC
Health Insurers who recognize a solution for chronic symptoms